U.S. markets open in 6 hours 11 minutes

Brickell Biotech, Inc. (BBI)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.8575-0.0114 (-1.31%)
At close: 4:00PM EDT

Brickell Biotech, Inc.

5777 Central Avenue
Suite 102
Boulder, CO 80301
United States
720 505 4755

Full Time Employees13

Key Executives

NameTitlePayExercisedYear Born
Mr. Reginald L. Hardy M.B.A., R.Ph.Co-Founder & Chairman74kN/A1958
Attorney Robert Busard BrownCEO & Director711kN/A1962
Mr. Andrew D. SklawerCo-Founder, COO & Sec.492.5kN/A1985
Mr. Deepak ChadhaChief R&D Officer479.83kN/A1970
Mr. Albert Nicholas Marchio IIChief Financial OfficerN/AN/A1952
Mr. Jose BretonController & Chief Accounting OfficerN/AN/A1989
Mr. David R. Mcavoy J.D.Gen. Counsel & Chief Compliance OfficerN/AN/A1963
Mr. Gary S. WalkerChief Marketing OfficerN/AN/A1960
Ms. Sue FattorHead of Human ResourceN/AN/AN/A
Ms. Nancy SerettaVP & Head of Clinical OperationsN/AN/AN/A
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Brickell Biotech, Inc., a clinical-stage pharmaceutical company, focuses on identifying, developing, and commercializing various prescription therapeutics for the treatment of debilitating skin diseases in the United States. The company's lead product candidate is sofpironium bromide that is in phase 3 clinical trial to treat patients with primary axillary hyperhidrosis. It has a collaboration agreement with AnGes, Inc. for the development of a novel DNA vaccine candidate for COVID-19. The company was founded in 2009 and is headquartered in Boulder, Colorado.

Corporate Governance

Brickell Biotech, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.